| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6099439 | Journal of Crohn's and Colitis | 2013 | 8 Pages |
Abstract
Allopurinol and thiopurine combination-therapy seems to increase HGPRT and decrease XO activity in IBD patients, which at least in part may explain the observed changes in thiopurine metabolite concentrations.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
M.L. Seinen, D.P. van Asseldonk, N.K.H. de Boer, N. Losekoot, K. Smid, C.J.J. Mulder, G. Bouma, G.J. Peters, A.A. van Bodegraven,